Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
4,610.70
-58.10 (-1.24%)
Nov 18, 2026, 3:28 PM IST
Torrent Pharmaceuticals Revenue
Torrent Pharmaceuticals had revenue of 49.79B INR in the quarter ending September 30, 2026, with 50.79% growth. This brings the company's total for the last twelve months to 174.00B, up 42.06% year-over-year. In the fiscal year ending March 31, 2026, Torrent Pharmaceuticals had annual revenue of 139.80B with 21.39% growth.
Revenue (ttm)
174.00B
Revenue Growth
+42.06%
P/S Ratio
10.08
Revenue / Employee
9.53M
Employees
18,258
Market Cap
1.75T
Revenue by Geography
- India 81.61B 58.4%
- Other Countries 18.45B 13.2%
- United States 13.63B 9.7%
- Brazil 13.62B 9.7%
- Germany 12.49B 8.9%
Fiscal year ended Mar 31, 2026 See the full Torrent Pharmaceuticals breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 139.80B | 24.64B | 21.39% |
| Mar 31, 2025 | 115.16B | 7.88B | 7.35% |
| Mar 31, 2024 | 107.28B | 11.08B | 11.51% |
| Mar 31, 2023 | 96.20B | 11.12B | 13.07% |
| Mar 31, 2022 | 85.08B | 5.03B | 6.29% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 616.31B |
| Aurobindo Pharma | 369.13B |
| Zydus Lifesciences | 303.78B |
| Cipla | 279.89B |
| Glenmark Pharmaceuticals | 159.97B |
| Alkem Laboratories | 156.32B |
| Mankind Pharma | 153.79B |
| Divi's Laboratories | 121.91B |
Torrent Pharmaceuticals News
- 26 days ago - Torrent Pharmaceuticals Transcript: Q2 26/27 - Transcripts
- 26 days ago - Torrent Pharmaceuticals Quarterly report: Q2 2027 - Filings
- 26 days ago - India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand - Reuters
- 3 months ago - Torrent Pharmaceuticals Transcript: Q1 26/27 - Transcripts
- 3 months ago - Torrent Pharmaceuticals Quarterly report: Q1 2027 - Filings
- 3 months ago - Torrent Pharmaceuticals Slides: Q1 2027 - Filings
- 4 months ago - JB Chemicals amalgamates with Torrent Pharma as scheme becomes effective - Business Upturn
- 4 months ago - Torrent Pharmaceuticals completes amalgamation with J.B. Chemicals - Business Upturn